The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTFB.L Share News (MTFB)

  • There is currently no data for MTFB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Fuller Smith & Turner Gets GBP100 Million

Mon, 01st Jun 2020 11:16

(Alliance News) - The following is a round-up of updates by London-listed companies on the impact of the Covid-19 pandemic, issued on Monday and not separately reported by Alliance News:

----------

Fuller Smith & Turner PLC - pubs - To issue commercial paper under Covid Corporate Financing facility for initial sum of GBP100 million, allowing GBP155 million revolving credit facility to remain undrawn. Placed 96% of employees on furlough, while executives and board members volunteered for pay reduction.

----------

Arricano Real Estate PLC - property - All five shopping centres in Ukraine open with effect on Saturday last week, as restrictions by local authorities on access to shopping centres lifted. However, food courts, cinema and entertainment centres will remain closed.

----------

Topps Tiles PLC - tile retail - To sale and leaseback head office in Enderby, Leicester, to UK Warehouse Properties Ltd for GBP18.1 million. Proceeds expected to strengthen group's financial position in the face of the Covid-19 crisis.

----------

Mattioli Woods PLC - wealth management - Annual revenue to be ahead of GBP58.5 million reported the year before. Profit to be ahead of management expectations. Directors to take 50% reduction in salaries and fees until end of June, while chief executive officer takes no salary at all. Group in strong financial position following the acquisition of Hurley Partners in March.

----------

Motif Bio PLC - cash shell - Remains in negotiations with several reverse takeover candidates in the healthcare sector, as the pandemic creates new opportunities for healthcare firms.

----------

CloudCall Group PLC - communications - Expects to have enough cash to fund it through period of macroeconomic uncertainty. Continues to report ongoing challenges within the broader marketplace, which has near-term impact on the sales pipeline. Year-to-date sales bookings from new customers 28% less than same period the year before.

----------

Zoetic International PLC - cannabidiol - Signs distribution agreement with partner BettermentRS to market tobacco-alternative Chill products to its network of outlets. Rollout of Chill brand delayed by pandemic, as many retail outlets closed on lockdown restrictions.

----------

MJ Hudson Group PLC - asset management - Reports strong sales activity and levels of client work during lockdown period. Confident in achieving profit for year ending June 30 in line with market expectations, despite revenue disruption due to the lack of new fund launch activity.

----------

Marshall Motor Holdings PLC - cars - Trading significantly ahead of UK market in first quarter of 2020. As lockdown eases, group gradually expanded its offering of aftersales services, with initial demand encouraging. Furloughed 90% of employees during lockdown period as many stores closed. To post a pretax loss for the first half of 2020.

----------

Braveheart Investment Group PLC - investments - Subsidiary Paraytec Ltd to launch project with University of Sheffield to develop a rapid test for Covid-19 test, which will utilise highly sensitive light-based detection system coupled with a molecular "affinity" device to capture Covid-19 virus particles. Paraytec to own all foreground intellectual property generated by the project.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
1 Apr 2019 16:48

Amphion Innovations Pledges Polarean Shares As Extra Security For Loan (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC said Monday it has pledged its holding in Polarean Imaging PLC as additional security against its loan facility with its debt in Amphion closed 22%

Read more
20 Mar 2019 10:31

WINNERS & LOSERS SUMMARY: Inmarsat Up As Private Equity Firms Make Bid

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - Group, up 1.1%. The telecommunications was

Read more
19 Mar 2019 16:20

Amphion Innovations Sells More Shares In Motif Bio As Loan Repayment (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC on Tuesday said it sold 3.3 million shares in its Motif Bio PLC partner company as a partial loan repayment.Amphion Innovations develops and

Read more
18 Mar 2019 11:46

Motif Bio Chair Morgan Stands Down, Williams Becomes Interim Chair

LONDON (Alliance News) - Motif Bio PLC said Monday Chair Richard Morgan had resigned from the biopharmaceutical firm, to be replaced by biopharma veteran Bruce Williams as interim - who also as of

Read more
15 Mar 2019 09:26

Amphion Innovations Sells Partner's Motif Bio Shares In Loan Repayment (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC on Friday said it sold 1.8 million shares in partner pharmaceutical company Motif Bio PLC to repay a loan facility.Amphion made USD144,000

Read more
11 Mar 2019 18:11

Amphion Innovations Agrees To Amend 2014 Loan Facility (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC said Monday it has amended its loan facility first agreed in 2014 and then amended last October.Amphion amended the loan interest rate to to

Read more
18 Feb 2019 10:43

WINNERS & LOSERS SUMMARY: Reckitt Rises After Strong Annual Results

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------Reckitt its

Read more
18 Feb 2019 09:27

Motif Bio Will Need Fundraise After Agreeing To Repay Part of Loan

LONDON (Alliance News) - Shares in Motif Bio PLC plunged on Monday as its subsidiary, Motif Biosciences Inc signed an amendment agreement with lender Hercules Capital Inc over a loan agreement in

Read more
15 Feb 2019 16:34

Invesco Lowers Motif Bio Interest By More Than 10% (ALLISS)

LONDON (Alliance News) - Motif Bio PLC on Friday said that Invesco Ltd has cut its stake in the company by more than 10%.Prior to Friday's deal, Invesco held a 24.98% interest in the it

Read more
14 Feb 2019 11:47

Motif Bio crashes as FDA calls for more data

(Sharecast News) - Motif Bio said it will need to raise new funds after the application for its skin infections treatment, iclaprim, was refused by the US drug regulator in its present form.

Read more
14 Feb 2019 11:17

WINNERS & LOSERS SUMMARY: ConvaTec Slumps On "Disappointing" Results

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------Micro up

Read more
5 Feb 2019 10:56

Motif Bio Receives GBP36,500 Following Warrants Exercise (ALLISS)

LONDON (Alliance News) - Motif Bio PLC on Tuesday said it has netted GBP36,514 following the exercise of share warrants.The pharmaceutical company said 113,396 warrants were exercised at a

Read more
16 Oct 2018 11:38

Amphion Innovations Restructures Loan And Agrees Further Drawdown

LONDON (Alliance News) - Amphion Innovations PLC on Tuesday said it has restructured its loan payments and agreed a further USD1.1 million draw-down.Amphion's shares dropped 12% to 0.66

Read more
21 Aug 2018 10:50

Amphion Innovations Sells Motif Bio Shares To Repay Loan Facility (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC said Tuesday it sold 3 million shares in Motif Bio PLC to institutional investors at 33.5 pence each, lowering its stake in the company to company

Read more
8 Aug 2018 12:28

Motif Bio Gets Patent Permission In US For Antibiotic Iclaprim

LONDON (Alliance News) - Motif Bio PLC said Wednesday it has been given a Notice of Allowance from the US Patent & Trademark Office for use of its antibiotic, iclaprim, to treat bacterial that

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.